Who are Colchicine Tablets's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Navelbine, Oncovin, Oncovin, Colcrys, Cipterbin Combined With Vinorelbine, Migranal nasal spray at 4 hour.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/colchicine-tablets.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Colchicine Tablets — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Colchicine Tablets (Colchicine Tablets) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Alkaloid [EPC].

marketed Alkaloid [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

Colchicine Tablets (Colchicine Tablets) — Shanghai Public Health Clinical Center.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Colchicine Tablets TARGET	Colchicine Tablets	Shanghai Public Health Clinical Center	marketed	Alkaloid [EPC]
Navelbine	vinorelbine	Pierre Fabre	marketed	Vinca Alkaloid	Substance-K receptor	1994-01-01
Oncovin	Vincristine Sulfate	Pfizer Inc.	marketed	Vinca Alkaloid	Canalicular multispecific organic anion transporter 1	1963-01-01
Oncovin	vincristine	Pfizer Inc.	marketed	Vinca Alkaloid	Canalicular multispecific organic anion transporter 1	1963-01-01
Colcrys	COLCHICINE	Scilex Pharms	marketed	Alkaloid [EPC]	Serine/threonine-protein kinase pim-1	1961-01-01
Cipterbin Combined With Vinorelbine	Cipterbin Combined With Vinorelbine	Zhejiang Cancer Hospital	marketed	Tyrosine kinase inhibitor combined with vinca alkaloid	Multiple tyrosine kinases (cipterbin); tubulin (vinorelbine)
Migranal nasal spray at 4 hour	Migranal nasal spray at 4 hour	Thomas Jefferson University	marketed	Ergot alkaloid; 5-HT1B/1D receptor agonist	5-HT1B receptor, 5-HT1D receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Alkaloid [EPC] class)

Scilex Pharms · 1 drug in this class
Shanghai Public Health Clinical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Colchicine Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/colchicine-tablets. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing